From: Damage effect of high-intensity focused ultrasound on breast cancer tissues and their vascularities
Control group (n = 25) | HIFU group (n = 25) | p value | |
---|---|---|---|
Tumor size: mean (range) | 2.3~4.5 cm | 2.1~4.8 cm | p = NS |
Breast cancer TNM staging: n (%) | |||
Stage I | 7 (28.0 %) | 6 (24.0 %) | p = NS |
Stage IIa | 5 (20.0 %) | 4 (16.0 %) | |
Stage IIb | 13 (52.0 %) | 15 (60.0 %) | |
Not reported | 0 (0.0 %) | 0 (0.0 %) | |
Histopathologic grade | |||
G1 well differentiated | 12 (48.0 %) | 10 (40.0 %) | p = NS |
G2 moderately differentiated | 9 (36.0 %) | 12 (48.0)% | |
G3 poorly differentiated | 4 (16.0 %) | 3 (12.0 %) | |
Receptor status | |||
ER+/PR+ | 14 (56.0 %) | 13 (52.0 %) | p = NS |
ER+/PR− | 2 (8.0 %) | 4 (16.0 %) | |
ER−/PR− | 8 (32.0 %) | 7 (28.0 %) | |
Histological subtype | |||
Infiltrating ductal carcinoma | 14 (56.0 %) | 13 (52.0 %) | p = NS |
Infiltrating lobular carcinoma | 5 (20.0 %) | 7 (28.0 %) | |
Other subtype | 6 (24.0 %) | 5 (20.0 %) | |
Ipsilateral lymph node metastasis | |||
Sentinel lymph node biopsy | 10 (40.0 %) | 10 (40 %) | p = NS |
Postoperative permanent pathology | 11 (44.0 %) | 12 (48 %) | |
Not reported | 0 (0.0 %) | 0 (0 %) | |
Lesion location: side | |||
Left side | 12 (48.0 %) | 14 (56.0 %) | p = NS |
Right side | 13 (52.0 %) | 11 (44.0 %) | |
Lesion location: vertical | |||
Upper | 7 (28.0 %) | 9 (36.0 %) | p = NS |
Lower | 11 (44.0 %) | 10 (40.0 %) | |
Midline | 7 (28.0 %) | 5 (20.0 %) | |
Lesion location: horizontal | |||
Upper | 7 (28.0 %) | 9 (36.0 %) | p = NS |
Lower | 11 (44.0 %) | 10 (40.0 %) | |
Midline | 7 (28.0 %) | 5 (20.0 %) |